Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC (BMIC-012)
from The Beacon (Audio) Hosted by H. Jack West, MD
Dr. Jack West reviews evidence that a subset of patients with advanced NSCLC demonstrate "hyper-progressing disease" (HPD), worsening cancer at a faster rate, on immune checkpoint inhibitor therapy, more commonly than seen in patients on chemotherapy.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The Beacon (Audio)?
This episode is 7 minutes long.
When was this The Beacon (Audio) episode published?
This episode was published on October 27, 2017.
Can I download this The Beacon (Audio) episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.